AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerhard, G. T
Right arrow Articles by Connor, W. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerhard, G. T
Right arrow Articles by Connor, W. E
Agricola
Right arrow Articles by Gerhard, G. T
Right arrow Articles by Connor, W. E
American Journal of Clinical Nutrition, Vol. 70, No. 2, 252-260, August 1999
© 1999 American Society for Clinical Nutrition


Original Research Communications

Higher total homocysteine concentrations and lower folate concentrations in premenopausal black women than in premenopausal white women1,2,3

Glenn T Gerhard, M Rene Malinow, Thomas G DeLoughery, Adam J Evans, Gary Sexton, Sonja L Connor, Rosemary C Wander and William E Connor

1 From the Division of Endocrinology, Diabetes, and Clinical Nutrition; the Division of Laboratory Medicine, Department of Pathology; and the Division of Hematology and Medical Oncology, Department of Medicine, General Clinical Research Center, Portland, OR; the Oregon Regional Primate Research Center, Beaverton, OR; and Oregon State University, Department of Nutrition and Food Management, Corvallis.

2 Supported by grant 93-37200-8963 from the US Department of Agriculture and General Clinical Research Centers Program RR59, Bureau of Research Resources, National Institutes of Health, Bethesda, MD.

3 Address reprint requests to GT Gerhard, Department of Medicine, L465, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098. E-mail:gerhard{at}ohsu.edu.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background:Premenopausal black women have a greater rate of coronary artery disease (CAD) than do premenopausal white women. Plasma total homocysteine concentrations, a risk factor for CAD, have not been reported in premenopausal black women.

Objective: The purpose of this study was to compare plasma total homocysteine, folate, and vitamin B-12 concentrations in premenopausal black and white women.

Design: Eighty-nine black and 90 white, healthy, premenopausal women living in Portland, OR, were recruited. Dietary histories were obtained by using the Diet Habit Survey, a 40-item eating-behavior questionnaire. Plasma concentrations of total homocysteine, folate, and vitamin B-12 were measured.

Results: Black women had higher plasma total homocysteine (8.32 compared with 7.60 µmol/L;P = 0.013), lower plasma folate (6.62 compared with 9.88 nmol/L;P < 0.0001), and higher vitamin B-12 (355 compared with 283 pmol/L;P < 0.001) concentrations than white women. White women had a greater rate of daily multivitamin supplement use (42.4% compared with 24.7%;P = 0.019) and ate more ready-to-eat cereal than did black women. After adjustment for multivitamin use and intake of ready-to-eat cereal, plasma total homocysteine concentrations did not differ significantly, but plasma folate remained significantly lower in the black women. None of the black women but 12.3% of the white women (P = 0.013) were homozygous for the cytosine to thymidine mutation at nucleotide 677 in the methylenetetrahydrofolate reductase gene.

Conclusions:Black women had higher plasma total homocysteine and lower plasma folate concentrations than white women, largely because of lifestyle factors, which may contribute to the greater rate of CAD in premenopausal black than in white women.

Key Words: Homocysteine • folic acid • vitamin B-12 • black women • white women • premenopause • coronary artery disease • multivitamins • ready-to-eat cereals • racial differences • methylenetetrahydrofolate reductase • MTHFR genotype


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Premenopausal black women have a 2–3-fold greater rate of coronary artery disease than do premenopausal white women (14). Increased rates of obesity (5) and hypertension (6) in black women likely contribute to their greater rate of coronary artery disease. Although plasma total and LDL-cholesterol concentrations are similar between the races (7), black women have higher HDL-cholesterol (8) and lower triacylglycerol (9) concentrations than white women. Thus, the overall lipoprotein profile is less, not more, atherogenic in black women. Although concentrations of plasma total homocysteine—an independent risk factor for coronary artery disease, stroke, and peripheral arterial disease (1012)—have been reported in premenopausal white women (13), no studies have reported plasma homocysteine concentrations in premenopausal black women. If a racial disparity in plasma total homocysteine exists, it could contribute to the higher rate of coronary artery disease in premenopausal black than in white women.

The primary hypothesis of this study was that premenopausal black women have higher fasting plasma total homocysteine concentrations than comparable white women. Therefore, we compared plasma total homocysteine concentrations in a sample of healthy black and white premenopausal women. Plasma concentrations of folate and vitamin B-12, 2 vitamins that play an important role in homocysteine metabolism (11,12,14,15), were also measured. In a subset of women, the methylenetetrahydrofolate reductase (MTHFR) genotype was determined. Dietary data and information concerning the use of multivitamin supplements were also collected.


    SUBJECTS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Subjects
One hundred black and 100 white premenopausal women aged 18–45 y were recruited, by using quota sampling, for participation in a study that examined racial differences in several coronary artery disease risk factors (16). Potential participants were considered black if they defined themselves as black. Complete data for plasma total homocysteine, folate, and vitamin B-12 were available in 89 black and 90 white women, who are the subject of this report. This study was approved by the Institutional Review Board at the Oregon Health Sciences University (OHSU). Women were recruited from OHSU employees, mothers of children attending the Albina Head Start school readiness program, Albina Head Start employees, and the general Portland, OR, community. Recruitment methods included advertisements in the OHSU campus newsletter, in Portland newspapers, and on the radio, and by word of mouth among Albina Head Start mothers and staff. All participants were healthy and had regular menstrual periods. Women with diabetes, who had renal or hepatic diseases, or who were currently abusing alcohol or illicit drugs were excluded. Written, informed consent was obtained from all participants.

Methods
The evaluation procedure included a medical and dietary history and measurement of height, weight, and blood pressure. In addition, a venipuncture was conducted after a 12-h fast for determination of plasma total homocysteine, folate, and vitamin B-12 concentrations;MTHFR genotype; and concentrations of plasma creatinine, which may be correlated with fasting plasma total homocysteine concentrations (17). The dietary history was obtained by dietitians trained in using the Diet Habit Survey, a previously validated 40-item eating-behavior questionnaire developed at OHSU for assessment of dietary intake over the preceding month (18). Information was obtained about the intake of foods rich in folates, including fruit, vegetables, legumes, and especially ready-to-eat cereals (19). About 95% of ready-to-eat cereals are fortified with folic acid and most of these cereals provide 25% of the recommended dietary allowance (20) for folate per serving of cereal. The serving size for ready-to-eat cereals ranges from 0.12 to 0.24 L (0.5 to 1 cup). At the time our study was conducted, ready-to-eat cereals were, perhaps, the largest supplemented source of folic acid in the United States (21). Intakes (g/d) of meat, fish, poultry, and cheese—rich sources of vitamin B-12 (22)—were also determined. The intake of foods rich in vitamin B-6, including meats, beans, and fortified cereals, was also assessed in the Diet Habit Survey. Whole-grain products are also rich in vitamin B-6, although their intake could not be precisely quantitated. The dietary intake of methionine, which is present in meat products (23) and may influence plasma total homocysteine concentrations (24,25), could not be quantified from the Diet Habit Survey. Finally, alcohol intake, which is associated with lower plasma folate (26) and higher plasma total homocysteine (27) concentrations, was also measured in the Diet Habit Survey by categorizing subjects into 1 of 5 groups ranging from <1 drink/wk to >=1 drink/d [1 drink = 360 mL (12 oz) beer, 45 mL (1.5 oz) spirits, or 120 mL (4 oz) wine].

The women were asked whether they took a multivitamin supplement daily. Women were additionally queried about how many years of schooling they had completed and their total family income, which was grouped into 8 categories ranging from <$5000 to >$80000/y. Educational attainment and income are frequently used as measures of socioeconomic status (28,29), which may be linked to multivitamin supplement use (30). The women were also asked whether they currently smoked cigarettes because smoking has been associated with lower plasma folate (31,32) and higher plasma total homocysteine (33) concentrations.

Laboratory analyses
Plasma total homocysteine, folate, and vitamin B-12
Approximately 10 mL fasting venous blood was drawn into a tube containing EDTA as anticoagulant. The plasma was separated immediately by centrifugation (2000 xg, 10 min, 4°C) and stored at -80°C until analyzed. Plasma total homocysteine concentrations were determined by HPLC as described previously (34,35). The interassay CV for the homocysteine assay was 9.1% (36). Plasma concentrations of folate and vitamin B-12 were measured by using the Quantaphase II B- 12/folate radioassay kit provided by Bio-Rad Laboratories, Hercules, CA (37). The normal range for plasma folate with this method in our laboratory is 3.4–46.7 nmol/L(CV: 8.0%) and for vitamin B-12 is 96–568 pmol/L (CV: 6.8%).

MTHFR genotyping by polymerase chain reaction
Preliminary racial differences in plasma total homocysteine concentrations observed after the study began aroused our interest; therefore, theMTHFR genotype, which may be related to plasma total homocysteine concentrations (38), was determined in a subset of women (50 black and 57 white). DNA was extracted from frozen plasma by double phenol-chloroform extraction (AJ Evans, TG Deloughery, RD Press, unpublished observations, 1996) and theMTHFR genotype determined by using the polymerase chain reaction as described previously (38). TheMTHFR genotype was classified as wild type (C677C: 2 cytosines at nucleotide 677), heterozygous (C677T: substitution of one of the cytosines with thymidine), or homozygous for the mutation (T677T: substitution of both cytosines with thymidine).

Plasma creatinine
The plasma creatinine concentration was determined by using the Jaffé rate method (39), a colorimetric procedure based on the formation of a red color complex on addition of the plasma sample to an alkaline picrate solution.

Statistical methods
A Kolmogorov-Smirnov test was used to determine whether the distribution of variables departed significantly from normality (40). Because the plasma total homocysteine, folate, and vitamin B-12 distributions were skewed, log10 transformations were performed on these variables. The log transformations improved normality in the homocysteine data and ameliorated the skewness in the folate and vitamin B-12 distributions. Statistical analyses were performed on the log-transformed variables and geometric means reported. Plasma total homocysteine, folate, vitamin B-12, and creatinine concentrations were compared between the races by using an unpairedt test (41). Dietary intakes of ready-to-eat cereals, fruit and vegetables, legumes, meat (including fish and poultry), cheese, and alcohol, as well as educational attainment (in y) and family income level were compared by using the Mann-Whitney rank-sum test (42) because these variables were not normally distributed and log transformation did not normalize the data. Thus, these variables are reported as medians. Least-squares linear regression (43) of log10 plasma total homocysteine on log10 plasma folate was performed to determine whether the relation between plasma total homocysteine and folate concentrations was similar or different between the races.

The chi-square test (42) was used to analyze categorical variables, including the percentage of black women compared with white women who had low or low-normal plasma folate concentrations, the percentage of black and white women taking a daily multivitamin supplement, and the race-specific prevalence of cigarette smoking. Multiple linear regression analysis (43) of daily multivitamin use (yes or no; dependent variable) on race, educational attainment, and income level (independent variables) was performed to determine the influence of socioeconomic status on multivitamin use in black and white women. A two-way analysis of variance procedure (multivitamin use by race) was performed on the log-transformed variables to ascertain the influence of multivitamin use on plasma total homocysteine, folate, and vitamin B-12 concentrations in both races (42). Spearman rank-order correlation coefficients (rs) (42) were computed to test for a relation between meat and cheese intake and plasma vitamin B-12 concentrations.

Multiple linear regression analysis (43) of log10 plasma total homocysteine on race, log10 plasma folate, log10 plasma vitamin B-12, plasma creatinine concentration, current cigarette smoking (yes or no), alcohol intake, daily multivitamin use (yes or no), intake of ready-to-eat cereal, fruit and vegetable intake, and legume intake was used to determine factors predictive of plasma total homocysteine concentrations. To ascertain factors predictive of plasma folate concentrations, multiple linear regression analysis of log10 plasma folate on likely predictors was performed, including race, daily multivitamin use (yes or no), intake of ready-to-eat cereal, fruit and vegetable intake, legume intake, current cigarette smoking (yes or no), and alcohol intake. The interaction of alcohol intake and race was included in the log10 plasma folate multiple regression model (40) to determine whether the relation between plasma folate concentrations and alcohol intake was similar between the races.

The distribution ofMTHFR genotypes (wild type, heterozygous, or homozygous) was determined in a subset of 50 black and 57 white women and the distribution was compared by using the chi-square test. A chi-square test was also used to compare the C677T allele frequency between black and white women. Plasma total homocysteine and folate concentrations were compared between white and black women with the wild typeMTHFR genotype by using an unpairedt test.

Two-tailedP values <0.05 were regarded as significant. The statistical analyses were performed by using SIGMASTAT (version 1.0; Jandel Scientific Software, Rafael, CA) and the graphics displays were created with SIGMAPLOT (version 2.0; Jandel Scientific Software).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Clinical and demographic characteristics
There were no significant differences in age or educational attainment between black and white women (Table 1Go). The typical black and white women participating in our study had some college education. Both the white and the black women were better educated than comparably aged white and black women in Portland, OR (44), and in the United States as a whole (45). The combined family income levels did not differ significantly between the races, nor did the percentages of black and white women who were current cigarette smokers. The median alcohol intake was low and not significantly different between the races. Black women had a significantly higher mean body mass index and significantly higher systolic and diastolic blood pressures than white women.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Baseline characteristics of premenopausal black and white women1
 
Plasma total homocysteine, folate, and vitamin B-12
Plasma total homocysteine concentrations were significantly higher in black than in white women (Table 2Go). The black women had significantly lower plasma folate concentrations than the white women. A greater percentage of black (44.9%) than white (24.4%) women had low (<3.4 nmol/L) or low- normal (3.4–5.9 nmol/L) plasma folate concentrations (P = 0.006). Least-squares linear regression analysis (Figures1Go and2) indicated that the relation between plasma total homocysteine and folate did not differ significantly between black and white women. Vitamin B-12 concentrations were significantly higher in the black than in the white women.


View this table:
[in this window]
[in a new window]
 
TABLE 2. Plasma total homocysteine, folate, and vitamin B-12 concentrations in premenopausal black andwhite women screened for coronary artery disease risk factors in Portland, OR1
 


View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 1. Least-squares regression of log10 plasma total homocysteine (dependent variable) on log10 folate (independent variable) in black women (n = 89).

 
Multivitamin use
A greater percentage (P = 0.019) of white (42.4%) than black (24.7%) women took a daily multivitamin supplement. The most frequently used brands of multivitamin supplements were Centrum (Lederle Consumer Health, Madison, NJ), One-A-Day (Bayer Corp, Morristown, NJ), and Theragran-M (Mead Johnson, Evansville, IN), each of which provided 400 µg folic acid, 6–9 µg vitamin B-12, and 2–3 mg vitamin B-6. No subject was consuming supplemental folic acid, vitamin B-12, or vitamin B-6 apart from the daily multivitamin supplement. In a multiple linear regression analysis of multivitamin intake (yes or no) on race, educational attainment in years, and income level, only race was a significant predictor of multivitamin use (P = 0.039).

Regular users of multivitamin supplements had significantly lower plasma total homocysteine concentrations than nonusers (Table 3Go). After adjustment for multivitamin use, plasma total homocysteine concentrations did not differ significantly between black and white women. Plasma folate concentrations were significantly higher in multivitamin supplement users than in nonusers and in white women than in black women in both categories of multivitamin use. There was no difference in vitamin B-12 concentrations between users and nonusers of multivitamin supplements.


View this table:
[in this window]
[in a new window]
 
TABLE 3. Plasma total homocysteine, folate, and vitamin B-12 concentrations by race and multivitamin use inblack and white premenopausal women screened for coronary artery disease risk factors1
 
Dietary intakes
The median intake of ready-to-eat cereals was significantly greater in white than in black women (Table 4Go). Median intakes of fruit and vegetables and of legumes did not differ significantly between the races. Black women consumed more meat, fish, poultry, and cheese than did white women. There was no correlation of plasma vitamin B-12 concentrations with meat and cheese intake in either race.


View this table:
[in this window]
[in a new window]
 
TABLE 4. Dietary intakes of foods rich in folates or vitamin B-12 in premenopausal black and white women1
 
Plasma creatinine
The mean plasma creatinine concentration did not differ significantly between the races: 66.30 ± 13.26 µmol/L (0.75 ± 0.15 mg/dL) in black women and 65.42 ± 11.49 µmol/L (0.74 ± 0.13 mg/dL) in white women.

Methylenetetrahydrofolate reductase genotype
The distribution ofMTHFR genotypes was significantly different between black and white women (Table 5Go). No black women were homozygous for the mutation. The frequency of the C677T allele was lower in black (16%) than in white (32%) women (P = 0.011). BecauseMTHFR genotype status determines plasma total homocysteine response to folate depletion (38), we examined plasma total homocysteine and folate concentrations in patients with the wild typeMTHFR genotype. Black women with the wild type genotype had significantly higher mean plasma total homocysteine (8.48 compared with 6.98 µmol/L;P = 0.003) and lower folate (7.39 compared with 11.85 nmol/L;P = 0.001) concentrations than white women with the wild type genotype. Thus, when theMTHFR genotype was controlled for, the racial disparity in plasma total homocysteine and folate concentrations increased.


View this table:
[in this window]
[in a new window]
 
TABLE 5. Distribution of methylenetetrahydrofolate reductase (MTHFR) genotypes in premenopausal black and white women1
 
Multiple linear regression analyses
Multiple linear regression analyses were performed to ascertain factors predictive of plasma total homocysteine and folate concentrations and to elucidate reasons for the higher plasma total homocysteine and lower folate concentrations in black than in white women. Significant differences were found between black and white women in multivitamin use and intake of ready-to-eat cereal, so these variables were included in the regression models. Potential effect modifiers, including cigarette smoking, alcohol intake, plasma vitamin B-12 concentrations, plasma creatinine, fruit and vegetable intake, and legume intake were also included in the regression models.MTHFR genotype was not included as a possible predictor of plasma total homocysteine and folate concentrations because it was only determined in a subset of subjects.

Multiple linear regression analysis was carried out with log10 plasma total homocysteine concentrations (dependent variable) on race, log10 plasma folate, log10 plasma vitamin B-12, plasma creatinine, current cigarette smoking (yes or no), alcohol intake, daily multivitamin use (yes or no), intake of ready-to-eat cereal, fruit and vegetable intake, and legume intake (independent variables). Only log10 plasma folate was a significant predictor of the log10 plasma total homocysteine concentration (P < 0.0001). This regression model explained 26% of the variability in the log10 plasma total homocysteine concentration (adjustedR2 = 0.259). A multiple linear regression analysis of log10 plasma folate on race, daily multivitamin use (yes or no), intake of ready-to-eat cereal, fruit and vegetable intake, legume intake, current cigarette smoking (yes or no), and alcohol intake indicated that race (P = 0.004), multivitamin use (P < 0.0001), intake of ready-to-eat cereal (P < 0.0001), and alcohol consumption (P = 0.001) were significant predictors of log10 plasma folate. In this regression model the interaction term alcohol use x race was not a significant predictor of log10 plasma folate, indicating that the relation between alcohol use and plasma folate was similar in black and white women. The multiple linear regression model explained 32% of the variability in the log10 plasma folate concentration (adjustedR2 = 0.318).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The primary findings of this study were that premenopausal black women in the population studied had significantly higher concentrations of plasma total homocysteine and lower plasma folate concentrations than premenopausal white women. This was the first study to compare plasma total homocysteine concentrations in a sample of premenopausal black and white women. The higher plasma total homocysteine and lower folate concentrations in the black women were likely the result of their lower intakes of folate-containing multivitamin supplements and ready-to-eat cereal compared with the white women.

Premenopausal black women have a higher risk of coronary artery disease than do white women (14). Factors that may contribute to this increased risk include higher rates of obesity and hypertension and consumption of diets high in saturated fat and cholesterol (16). We identified plasma total homocysteine as an additional coronary artery disease risk factor, which is higher in premenopausal black than in white women.

The plasma total homocysteine concentration is an independent risk factor for the development of coronary artery disease (46), cerebrovascular disease (47), and peripheral arterial occlusive disease (34). Homocysteine may increase cardiovascular risk through injury to vascular endothelial cells (48), leading to vascular dysfunction (49) and to other changes that promote both atherogenesis and thombogenesis (48,50). Cardiovascular risk increases across the spectrum of homocysteine concentrations (47,51), much like plasma cholesterol. In Boushey et al's (51) meta-analysis, a 5-µmol/L increment in the plasma total homocysteine concentration was associated with a 60% increased risk for coronary artery disease in men and an 80% increased risk in women. However, definitive proof of a cause-and-effect relation between plasma total homocysteine and coronary artery disease awaits the results of ongoing controlled intervention trials.

Three vitamins—folic acid, vitamin B-12, and vitamin B-6—play an important role in homocysteine metabolism (Figure 3Go). The folic acid derivative 5-methyltetrahydrofolate, produced by the enzymatic reduction of 5,10- methylenetetrahydrofolate by MTHFR, acts as a methyl donor in the remethylation of homocysteine to methionine (14). Vitamin B-12 is an essential cofactor for 5-methyltetrahydrofolate–homocysteine in theremethylation reaction (11,12,14,15). Vitamin B-6, a necessary cofactor in the 2-step conversion of homocysteine to cysteine (14), plays an important role in determining the magnitude of the hyperhomocysteinemic response to a methionine load (14), but may be less important than plasma folate as a determinant of the fasting plasma total homocysteine concentration (52,53).



View larger version (16K):
[in this window]
[in a new window]
 
FIGURE 3. Homocysteine metabolism.

 
In an important study of homocysteine metabolism in black and white South African men (54), black men showed a smaller hyperhomocysteinemic response to methionine loading but had fasting plasma total homocysteine concentrations similar to those of white men. It is difficult to compare our findings with those of the study of South African men because South African blacks differ genetically from American blacks (55,56) and men rather than women were studied. Nevertheless, the South African data do indicate that, at least in South Africa, there may be genetic differences in homocysteine metabolism between blacks and whites that would not be reflected in their fasting plasma total homocysteine concentrations. These results must be interpreted with caution because of the relatively small sample size in that study (18 whites and 12 blacks).

As in our study, according to the 1987 National Health Interview Survey (57), a significantly greater percentage of white than of black women of reproductive age took a daily multivitamin supplement. In the National Health Interview Survey, daily multivitamin supplement use was strongly linked to socioeconomic status, which was not the case in our study. The racial difference in multivitamin supplement use we observed was possibly due to differences in unmeasured cultural or psychosocial factors that are not necessarily related to socioeconomic status (eg, unstable home environment and stress), which were associated with decreased vitamin intake in a prior study (58).

The black women in our study had a more marginal folic acid status than the white women, primarily because the black women had a lower rate of multivitamin use and lower intake of ready- to-eat cereals. Intakes of fruit and vegetables and legumes did not predict plasma folate concentrations. This may, in part, be secondary to a lower bioavailability of food folate than of synthetic folic acid in multivitamins and supplemented foods (59), which would lower the sensitivity of food folates as a predictor of plasma folate concentrations. In addition, the Diet Habit Survey does not differentiate between fruit and vegetables that are high or low in folates. The intake of alcohol, which interferes with folate utilization at multiple steps (22,26), was a predictor of plasma folate in the multiple linear regression model, but did not contribute to the racial difference in plasma folate concentrations. In contrast with the findings of other studies (31,32,60), cigarette smoking was not associated with plasma folate concentrations in our study, although the power to detect an association was limited by the low number of smokers in both races. Even after all of these predictors were accounted for, however, race remained a significant predictor of plasma folate concentrations. Thus, other unmeasured variables possibly associated with race also contributed to the racial difference in plasma folate concentrations.

A common point mutation (cytosine to thymidine) at nucleotide 677 in the gene coding for the MTHFR enzyme results in a thermolabile variant of the enzyme with reduced basal activity (61). This mutation is associated with higher plasma total homocysteine concentrations at a given plasma concentration of folate (62), and, in addition, directly lowers plasma folate concentrations by decreasing the formation of 5- methyltetrahydrofolate, the primary circulating form of folic acid (38,63). Thus, individuals homozygous for theMTHFR mutation have higher plasma total homocysteine concentrations (15,61,64) and are more sensitive to dietary folate depletion than are individuals without the mutation (38). Our study confirms earlier reports (15,6165) that the point mutation in theMTHFR gene is more common in white than in black women.

Finally, plasma vitamin B-12 concentrations were significantly higher in the black than in the white women. However, the higher plasma vitamin B-12 concentrations in the black women did not protect them from an increase in plasma total homocysteine concentrations associated with lower plasma folate concentrations. The higher meat and cheese intake of the black women was not the reason for their higher plasma vitamin B-12 concentrations because meat and cheese intake was not correlated with plasma vitamin B-12 concentrations.

One limitation of our study was that the Diet Habit Survey did not provide a precise measure of vitamin B-6 intake, although it did permit a comparison of the intakes of certain vitamin B- 6–rich foods (eg, meat, beans, and fortified cereals) between the races (66). Black women had a higher intake of meat, and white women ate more fortified cereal, whereas the intake of beans was similar between the races. On balance, it is unlikely that dietary vitamin B-6 intakes differed substantially between black and white women. The amount of vitamin B-6 in the multivitamin supplements (2–3 mg) was unlikely to have had a significant effect on fasting plasma total homocysteine concentrations, as supported by the results of a previous study (67).

In conclusion, the higher plasma total homocysteine and lower folate concentrations in premenopausal black than in premenopausal white women in our study were primarily the result of lifestyle factors. Our data suggest that higher plasma total homocysteine concentrations may contribute to the greater rate of coronary artery disease in premenopausal black than in white women, although prospective clinical trials are needed to prove this hypothesis. If the hypothesis is correct, regular intake of multivitamin supplements or folic acid alone and increased intakes of ready-to-eat cereals may be a cost-effective means of attenuating the high risk of coronary artery disease in premenopausal black women.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 2. Least-squares regression of log10 plasma total homocysteine (dependent variable) on log10 folate (independent variable) in white women (n = 90).

 

    ACKNOWLEDGMENTS
 
Special thanks to Sue Carey, Nancy Kimmons, Lillian Ashton, Nancy Smith, and the staff at the Albina Head Start main office in Portland for their help in subject recruitment and the use of their facility to screen volunteers; to Linda Banks for her help in recruiting subjects at the Oregon Health Sciences University; and to Donna Fitchett and the nurses and dietitians at the Clinical Research Center for their assistance in screening patients.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Garfinkel L. Cigarette smoking and coronary heart disease in blacks: comparison to whites in a prospective study.Am Heart J1984;108:802–7.[Medline]
  2. US Public Health Service. Vital statistics of the United States, 1987. Vol II. Mortality, Part A. Washington, DC: National Center for Health Statistics, 1990. [DHHS publication no. (PHS)90–1101.]
  3. Sungs JFC, Harris-Booker SA, Schmid G, Ford E, Simmons B, Reed JW. Racial differences in mortality from cardiovascular disease in Atlanta, 1979–1985.J Natl Med Assoc1992;84:259–63.[Medline]
  4. Gillum RF. Cardiovascular disease in the United States: an epidemiologic overview.Cardiovasc Clin1991;21:3–16.
  5. Najjar MF, Rowland M. Anthropometric reference data and prevalence of overweight, United States, 1976–1980. Vital Health Stat 11 1987;238:1–73. [DHHS publication no. (PHS) 87- 1688.]
  6. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population: data from the Health Examination Surveys, 1960–1991.Hypertension1995;26:60–9.[Abstract/Free Full Text]
  7. Cutter GR, Burke GL, Dyer AR, et al. Cardiovascular risk factors in young adults. The CARDIA baseline monograph.Control Clin Trials1991;12:1S–77S.[Medline]
  8. Carroll M, Sempos C, Briefel R, Gray S, Johnson C. Serum lipids of adults 20–74 years: United States, 1976–80. Vital Health Stat 11 1993;242:1–107. [DHHS publication no. (PHS) 93-1692.]
  9. Brown SA, Hutchinson R, Morrisette J, et al, for the ARIC Study Group. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities: the Atherosclerosis Risk in Communities (ARIC) Study.Arterioscler Thromb1993;13:1139–58.[Abstract/Free Full Text]
  10. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease.N Engl J Med1991;324:1149–55.[Abstract]
  11. Kang SS, Wong PWK, Malinow MR. Hyperhomocysteinemia as a risk factor for occlusive vascular disease.Annu Rev Nutr1992;12:279–98.[Medline]
  12. Malinow MR. Hyperhomocysteinemia: a common and easily reversible risk factor for occlusive atherosclerosis.Circulation1990;81:2004–6.[Free Full Text]
  13. Schwartz SM, Siscovich DS, Malinow MR, et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene.Circulation1997;96:412–7.[Abstract/Free Full Text]
  14. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma concentrations in health, disease, and drug therapy.J Lab Clin Med1989;114:473–501.[Medline]
  15. Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ, et al. Molecular genetic analysis in mild hyperhomocysteinemia—a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.Am J Hum Genet1996;58:35–41.[Medline]
  16. Gerhard GT, Sexton G, Malinow MR, et al. Premenopausal black women have more risk factors for coronary heart disease than white women.Am J Cardiol1998;82:1040–5.[Medline]
  17. Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma concentrations in middle-aged and elderly subjects.J Intern Med1994;236:633–41.[Medline]
  18. Connor SL, Gustafson JR, Sexton G, Becker N, Artaud-Wild S, Connor WE. The Diet Habit Survey: a new method of dietary assessment that relates to plasma cholesterol changes.J Am Diet Assoc1992;92:41–7.[Medline]
  19. Subar AF, Block G, James LD. Folate intake and food sources in the US population.Am J Clin Nutr1989;50:508–16.[Abstract/Free Full Text]
  20. National Research Council. Recommended dietary allowances. 10th ed. Washington, DC: National Academy Press, 1989.
  21. Nicklas TA, Myers S, Berenson GS. Total nutrient intake and ready-to-eat cereal consumption of children and young adults in the Bogalusa Heart Study.Nutr Rev1995;53:S39–45.[Medline]
  22. Herbert V, Das KC. Folic acid and vitamin B12. In: Shils ME, Olson JA, Shike M, eds. Modern nutrition in health and disease. 8th ed. Philadelphia: Lea and Febiger, 1994:402–25.
  23. Phipard EF. Protein and amino acids in diets. Improvements in protein nutriture. Washington, DC: National Academy of Sciences, 1974:167–83.
  24. Bostom AG, Lathrop L. Hyperhomocysteinemia in end stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes.Kidney Int1997;52:10–20.[Medline]
  25. Dennis VW, Robinson K. Homocysteinemia and vascular disease in end stage renal disease.Kidney Int1996;50:S11–7.
  26. Halsted EH. Alcohol and folate interactions: clinical implications. In: Bailey LB, ed. Folate in health and disease. 1st ed. New York: Marcell Dekker, Inc, 1994:313–27.
  27. Hultberg B, Berglund M, Andersson A, Frank A. Elevated plasma homocysteine in alcoholics.Alcohol Clin Exp Res1993;17:687–9.[Medline]
  28. Moorman PG, Hames CG, Tyroler HA. Socioeconomic status and morbidity and mortality in hypertensive blacks.Cardiovasc Clin1991;21:179–94.[Medline]
  29. Angell M. Privilege and health—what is the connection?N Engl J Med1993;329:126–7.[Free Full Text]
  30. Koplan JP, Annest JL, Layde PM, Rubin GL. Nutrient intake and supplementation in the United States (NHANES II).Am J Public Health1986;76:287–9.[Abstract/Free Full Text]
  31. Piyathilake CJ, Macaluso M, Hine RJ, Richards EW, Krumdieck CL. Local and systemic effects of cigarette smoking on folate and vitamin B-12.Am J Clin Nutr1994;60:559–66.[Abstract/Free Full Text]
  32. Ortega RM, Lopez-Sobaler AM, Gonzalez-Gross MM, et al. Influence of smoking on folate intake and blood folate concentrations in a group of elderly Spanish men.J Am Coll Nutr1994;13:68–72.[Abstract]
  33. Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study.JAMA1995;274:1526–33.[Abstract]
  34. Malinow MR, Kang SS, Taylor LM, et al. Prevalence of hyper-homocysteinemia in patients with peripheral arterial occlusive disease.Circulation1989;79:1180–8.[Abstract/Free Full Text]
  35. Malinow MR, Sexton G, Auerbach M, Grosman M, Wilson D, Upson B. Homocysteinemia in daily practice: concentrations in coronary artery disease.Coron Artery Dis1990;1:215–20.
  36. Malinow MR, Neito FJ, Kruger WSD, et al. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.Arterioscler Thromb Vasc Biol1997;17:1157–62.[Abstract/Free Full Text]
  37. Raiten DJ, Fisher KD. Assessment of folate methodology used in the third National Health and Nutrition Examination Survey (NHANES-III, 1988–1994).J Nutr1995;125:1371S–98S.
  38. DeLoughery TG, Evans A, Sadeghi A, et al. Common mutation in methylenetetrahydrofolate reductase: correlation with homocysteine metabolism and late-onset vascular disease.Circulation1996;94:3074–8.[Abstract/Free Full Text]
  39. Schurman SJ, Perlman SA, Chamizo W. Plasma creatinine results derived from an endpoint modification of the Jaffe method.Pediatr Nephrol1998;12:414–6.[Medline]
  40. Steel RGD, Torrie JH. Principles and procedures of statistics: a biometrical approach. 2nd ed. New York: McGraw-Hill Book Co, 1980.
  41. Devore J, Peck R. Statistics: the exploration and analysis of data. Los Angeles: West Publishing Company, 1986.
  42. Mattson DE. Statistics: difficult concepts, understandable explanations. Chicago: Bolchazy- Carducci Publishers, Inc, 1984.
  43. Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Applied linear regression models. 3rd ed. Chicago: Irving, Inc, 1989.
  44. US Department of Commerce, Bureau of the Census. 1990 Census of population: social and economic characteristics. Washington, DC: US Government Printing Office, 1992.
  45. US Department of Commerce, Bureau of the Census. Statistical abstract of the United States, 1993. The National Data Book. 113th ed. Washington, DC: US Government Printing Office, 1994.
  46. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians.JAMA1992;268:877–81.[Abstract]
  47. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery intimal medial wall thickening and plasma homocyst(e)ine in asymptomatic adults: the Atherosclerosis Risk in Communities Study.Circulation1993;87:1107–13.[Abstract/Free Full Text]
  48. Blann AD. Endothelial cell damage and homocysteine.Atherosclerosis1992;94:89–91.[Medline]
  49. Lentz SR, Sobey CG, Pregors DJ, et al. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.J Clin Invest1996;98:24–9.[Medline]
  50. McCully KS. Chemical pathology of homocysteine: I. Atherogenesis.Ann Clin Lab Sci1993;23:477–93.[Abstract]
  51. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease.JAMA1995;274:1049–57.[Abstract]
  52. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IM. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.JAMA1993;270:2693–8.[Abstract]
  53. Brattstrom L, Israelsson B, Norrving B, et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease: effects of pyridoxine and folic acid treatment.Atherosclerosis1990;81:51–60.[Medline]
  54. Ubbink JB, Vermaak WJH, Delport R, van der Merwe A, Becker PJ, Potgieter H. Effective homocysteine metabolism may protect South African blacks against coronary heart disease.Am J Clin Nutr1995;62:802–8.[Abstract/Free Full Text]
  55. The New Encyclopaedia Brittanica. 15th ed. Africa. Vol 11. Chicago: Encyclopedia Brittanica Inc, 1991:32–3.
  56. The New Encyclopedia Brittanica. 15th ed. Slavery. Vol 27. Chicago: Encyclopedia Brittanica Inc, 1991:285–98.
  57. Subar AF, Block G. Use of vitamin and mineral supplements: demographics and amounts of nutrients consumed. The 1987 Health Interview Survey.Am J Epidemiol1990;132:1091–101.[Abstract/Free Full Text]
  58. Suitor CW, Gardner JD. Supplement use among a culturally diverse group of low-income pregnant women.J Am Diet Assoc1990;90:268–71.[Medline]
  59. Duell PB, Malinow MR. Homocyst(e)inemia and risk of atheroscler-osis: a clinical approach to evaluation and management.Endocrinologist1998;8:170–7.
  60. McPhillips JB, Eaton CB, Gans KM, et al. Dietary differences in smokers and non-smokers from two southeastern New England communities.J Am Diet Assoc1994;94:287–92.[Medline]
  61. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease—a common mutation in methylenetetrahydrofolate reductase.Nat Genet1995;10:111–3.[Medline]
  62. Engbersen AMT, Franken DG, Boers GHJ, et al. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia.Am J Hum Genet1995;56:142–50.[Medline]
  63. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida.Lancet1995;346:1070–1.[Medline]
  64. Jacques P, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.Circulation1996;93:7–9.[Abstract/Free Full Text]
  65. McAndrew PE, Brandt JT, Pearl DK, Prior TW. The incidence of the gene for thermolabile methylenetetrahydrofolate reductase in African-Americans.Thromb Res1996;83:195–8.[Medline]
  66. Leklem JE. Vitamin B6. In: Shils ME, Olson JA, Shike M, eds. Modern nutrition in health and disease. 8th ed. Philadelphia: Lea and Febiger, 1994:383–94.
  67. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans.J Nutr1994;124:1927–33.



This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
V. Ganji and M. R Kafai
Population reference values for plasma total homocysteine concentrations in US adults after the fortification of cereals with folic acid.
Am. J. Clinical Nutrition, November 1, 2006; 84(5): 989 - 994.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. H. Criqui, V. Vargas, J. O. Denenberg, E. Ho, M. Allison, R. D. Langer, A. Gamst, W. P. Bundens, and A. Fronek
Ethnicity and Peripheral Arterial Disease: The San Diego Population Study
Circulation, October 25, 2005; 112(17): 2703 - 2707.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
V. Ganji and M. R. Kafai
Population References for Plasma Total Homocysteine Concentrations for U.S. Children and Adolescents in the Post-Folic Acid Fortification Era
J. Nutr., September 1, 2005; 135(9): 2253 - 2256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
V. Ganji and M. R Kafai
Frequent consumption of milk, yogurt, cold breakfast cereals, peppers, and cruciferous vegetables and intakes of dietary folate and riboflavin but not vitamins B-12 and B-6 are inversely associated with serum total homocysteine concentrations in the US population
Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1500 - 1507.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. E. Patrick, R. W. Powers, A. R. Daftary, R. B. Ness, and J. M. Roberts
Homocysteine and Folic Acid Are Inversely Related in Black Women With Preeclampsia
Hypertension, June 1, 2004; 43(6): 1279 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
V. Ganji and M. R Kafai
Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988-1994
Am. J. Clinical Nutrition, April 1, 2003; 77(4): 826 - 833.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerhard, G. T
Right arrow Articles by Connor, W. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerhard, G. T
Right arrow Articles by Connor, W. E
Agricola
Right arrow Articles by Gerhard, G. T
Right arrow Articles by Connor, W. E


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS